Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biological Quality In The Spotlight As UK MHRA Consults On Standard-Setting

Executive Summary

Quality standards for biological medicines are in the spotlight again, with the UK medicines regulator, the MHRA, in the midst of consulting stakeholders on how to ensure that publicly available monographs are suitable for biologicals in the future.


Related Content

UK MHRA To Explore Innovative Ways Of Setting Quality Standards For Biological Medicines
Feel The Quality: Biosimilars Dominate Standards Setting Debate In EU





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts